VIVEK SUBBIAH to B7-H1 Antigen
This is a "connection" page, showing publications VIVEK SUBBIAH has written about B7-H1 Antigen.
Connection Strength
0.111
-
Immunotherapy in non-small cell lung cancer harbouring driver mutations. Cancer Treat Rev. 2021 05; 96:102179.
Score: 0.030
-
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial. Invest New Drugs. 2021 06; 39(3):829-835.
Score: 0.029
-
Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors. ESMO Open. 2020 08; 5(4).
Score: 0.028
-
Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit. J Natl Compr Canc Netw. 2017 07; 15(7):863-866.
Score: 0.023